CLINICAL_TRIALS
research
· 2025-09-16
Clinical Trial Update: 177Lu-DOTATATE for Recurrent Meningioma [Phase 2]
Summary
Phase 2 clinical trial update for 177Lu-DOTATATE in recurrent meningioma; the study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Recurrent Meningioma | Phase 2 | Status: RECRUITING